Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EDAP TMS ( (EDAP) ) has shared an update.
EDAP TMS reported a strong performance in the second quarter of 2025, highlighted by a 140% year-over-year growth in net placements of its Focal One Robotic HIFU Systems and a 76.8% increase in HIFU revenue. The company also executed a letter of intent for a 36 million Euro credit facility with the European Investment Bank to support further growth and strategic expansion of its HIFU business. EDAP raised its 2025 HIFU revenue growth guidance to a range of 26% to 34%, reflecting the increasing demand for its Focal One platform. Despite a decline in its non-core business revenue, the company continues to focus on expanding its HIFU operations, supported by significant clinical evidence and growing adoption in the urology community.
The most recent analyst rating on (EDAP) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on EDAP TMS stock, see the EDAP Stock Forecast page.
Spark’s Take on EDAP Stock
According to Spark, TipRanks’ AI Analyst, EDAP is a Neutral.
EDAP’s overall stock score is primarily impacted by its financial performance challenges, including profitability and cash flow issues. Technical analysis indicates a bearish trend, while valuation concerns arise from its negative P/E ratio. The earnings call provided some positive strategic insights, but financial metrics remain a concern.
To see Spark’s full report on EDAP stock, click here.
More about EDAP TMS
EDAP TMS S.A. is a global leader in robotic energy-based therapies, specializing in High-Intensity Focused Ultrasound (HIFU) technology. The company focuses on providing innovative solutions for the treatment of prostate cancer, with its flagship product being the Focal One Robotic HIFU System.
Average Trading Volume: 55,624
Technical Sentiment Signal: Sell
Current Market Cap: $56.84M
Find detailed analytics on EDAP stock on TipRanks’ Stock Analysis page.